ArticleResearch square2025
Boosting AlphaFold Protein Tertiary Structure Prediction through MSA Engineering and Extensive Model Sampling and Ranking in CASP16.
Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Updated by
Authors and funding
3 authors.
Funding
Abstract
AlphaFold2 and AlphaFold3 have revolutionized protein structure prediction by enabling high-accuracy tertiary structure predictions for most single-chain proteins (monomers). However, obtaining high-quality predictions for some hard protein targets with shallow or noisy multiple sequence alignments (MSAs) and complicated multi-domain architectures remains challenging. Here, we present MULTICOM4, an integrative protein structure prediction system that uses diverse MSA generation, large-scale model sampling, and an ensemble model quality assessment (QA) strategy of combining individual QA methods to improve model generation and ranking of AlphaFold2 and AlphaFold3. In the 16th Critical Assessment of Techniques for Protein Structure Prediction (CASP16), our predictors built on MULTICOM4 ranked among the top performers out of 120 predictors in tertiary structure prediction and outperformed a standard AlphaFold3 predictor. The average TM-score of our best performing predictor MULTCOM's top-1 prediction for 84 CASP16 domain is 0.902. It achieved high accuracy (TM-score > 0.9) for 73.8% of the 84 domains and correct fold predictions (TM-score > 0.5) for 97.6% domains in terms of top-1 prediction. In terms of best-of-top-5 prediction, it predicted correct folds for all the domains. The results show that MSA engineering through the use of different protein sequence databases, alignment tools, and domain segmentation as well as extensive model sampling are the key to generate accurate and correct structural models. Additionally, using multiple complementary QA methods and model clustering can improve the robustness and reliability of model ranking.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.